NCT01629511 2020-02-24Allogeneic Stem Cell Transplant for CLLM.D. Anderson Cancer CenterPhase 1/2 Terminated15 enrolled 12 charts
NCT01116232 2019-03-26Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell TransplantationBarbara Ann Karmanos Cancer InstitutePhase 2 Terminated4 enrolled 4 charts
NCT01118013 2017-03-24Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell TransplantAlliance for Clinical Trials in OncologyPhase 2 Terminated6 enrolled 5 charts
NCT00818961 2013-12-18Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic CancerNorthside Hospital, Inc.Phase 2 Terminated36 enrolled 16 charts
NCT00827099 2012-03-23Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic CancerNorthside Hospital, Inc.Phase 2 Terminated5 enrolled 5 charts